Literature DB >> 16103201

Replication of varicella-zoster virus in human skin organ culture.

Shannon L Taylor1, Jennifer F Moffat.   

Abstract

Varicella-zoster virus (VZV) infection is restricted to humans, which hinders studies of its pathogenesis in rodent models of disease. To facilitate the study of VZV skin tropism, we developed an ex vivo system using human fetal skin organ culture (SOC). VZV replication was analyzed by plaque assay, transmission electron microscopy, and histology. The yield of infectious VZV from SOC increased approximately 100-fold over 6 days, virions were abundant, and lesions developed that contained VZV antigens and resembled varicella and zoster lesions. The SOC system for VZV replication has applications for testing virus mutants and antiviral drugs.

Entities:  

Mesh:

Year:  2005        PMID: 16103201      PMCID: PMC1193618          DOI: 10.1128/JVI.79.17.11501-11506.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.

Authors:  Takahiro Niizuma; Leigh Zerboni; Marvin H Sommer; Hideki Ito; Stewart Hinchliffe; Ann M Arvin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes.

Authors:  Tatiana Gianni; Gabriella Campadelli-Fiume; Laura Menotti
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Comparison of haemophilus influenzae type b interaction with respiratory mucosa organ cultures maintained with an air interface or immersed in medium.

Authors:  A D Jackson; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture.

Authors:  S Syrjänen; H Mikola; M Nykänen; V Hukkanen
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.

Authors:  Jaya Besser; Marvin H Sommer; Leigh Zerboni; Christoph P Bagowski; Hideki Ito; Jennifer Moffat; Chia-Chi Ku; Ann M Arvin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.

Authors:  Shannon L Taylor; Paul R Kinchington; Andrew Brooks; Jennifer F Moffat
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa.

Authors:  C F Rayner; A D Jackson; A Rutman; A Dewar; T J Mitchell; P W Andrew; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.

Authors:  J F Moffat; M D Stein; H Kaneshima; A M Arvin
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.

Authors:  Gyorgy Nagy; Maureen Barcza; Nick Gonchoroff; Paul E Phillips; Andras Perl
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

View more
  23 in total

Review 1.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

2.  Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.

Authors:  Naoki Inoue; Misato Matsushita; Yoshiko Fukui; Souichi Yamada; Mihoko Tsuda; Chizuka Higashi; Keiko Kaneko; Hideki Hasegawa; Toyofumi Yamaguchi
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

3.  Productive varicella-zoster virus infection of cultured intact human ganglia.

Authors:  Kavitha Gowrishankar; Barry Slobedman; Anthony L Cunningham; Monica Miranda-Saksena; Ross A Boadle; Allison Abendroth
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Human Three-Dimensional Models for Studying Skin Pathogens.

Authors:  Elena Boero; Malgorzata Ewa Mnich; Andrea Guido Oreste Manetti; Elisabetta Soldaini; Luca Grimaldi; Fabio Bagnoli
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

5.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

6.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.

Authors:  Chandrav De; Dongmei Liu; Bo Zheng; Uma S Singh; Satish Chavre; Catherine White; Robert D Arnold; Fred K Hagen; Chung K Chu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2014-07-19       Impact factor: 5.970

8.  Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions.

Authors:  Stacey A Leisenfelder; Paul R Kinchington; Jennifer F Moffat
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

9.  Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

Authors:  G N Malavige; L Jones; A P Black; G S Ogg
Journal:  Clin Exp Immunol       Date:  2008-03-20       Impact factor: 4.330

10.  A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.

Authors:  Megan G Lloyd; Nicholas A Smith; Michael Tighe; Kelsey L Travis; Dongmei Liu; Prashant K Upadhyaya; Paul R Kinchington; Gary C Chan; Jennifer F Moffat
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.